Trial intelligence / Profile preview

Intravenous Lidocaine for Anesthesia in Laparoscopic Surgery

NCT07193836Enrolling by invitation

Sponsor
General Hospital of Ningxia Medical University
Start
Sep 2025
Primary completion
Dec 2025
Modality
Small Molecules
Countries
1
01

Overview

Randomised, double-blind trial of Lidocaine Hydrochloride Injection, without epinephrine in gallbladder disease and Gynecologic disorders (3 arms), sponsored by General Hospital of Ningxia Medical University. Primary endpoints: Time to emergence from general anesthesia at Day 0 and Time to loss of consciousness at Day 0. Started Sep 2025; status: enrolling by invitation.

02

Drugs

Lidocaine Hydrochloride Injection, without epinephrine
03

Conditions

gallbladder diseaseGynecologic disorders

Beyond the preview

Go deeper on NCT07193836.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT07193836.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call